Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Kumararatne

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Immunology|January 1, 1997
Tuberculosis and immunodeficiency--of mice and menD S Kumararatne
Hospital Medicine (London, England : 1998)|March 4, 2000
BPL plasma products: new source, enhanced productsD S Kumararatne
Clinical and Experimental Immunology|September 1, 1992
The spleen? Who needs it anyway?M Hazlewood, D S Kumararatne
Clinical and Experimental Immunology|September 1, 1990
Selective IgG subclass deficiency: quantification and clinical relevanceR Jefferis, D S Kumararatne
The Ceylon Medical Journal|March 1, 1976
Undiagnosed aortic stenosis--a cause of death after mitral valvotomyP T Chandrasoma, D S Kumararatne
Clinical and Experimental Immunology|June 26, 2001
From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathiesS Y Patel, D S Kumararatne
Immunology Today|October 8, 2014
Another look at chronic lymphocytic leukaemia in the context of B-cell differentiationD S Kumararatne, N R Ling
European Journal of Immunology|November 1, 1981
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursorsD S Kumararatne, I C MacLennan
Advances in Experimental Medicine and Biology|January 1, 1982
The origin of marginal-zone cellsD S Kumararatne, I C MacLennan
Lancet (London, England)|September 9, 1989
Hyper-IgE syndrome and H2-receptor blockadeR A Thompson, D S Kumararatne
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Immunology|January 1, 1997
Tuberculosis and immunodeficiency--of mice and menD S Kumararatne
Hospital Medicine (London, England : 1998)|March 4, 2000
BPL plasma products: new source, enhanced productsD S Kumararatne
Clinical and Experimental Immunology|September 1, 1992
The spleen? Who needs it anyway?M Hazlewood, D S Kumararatne
Clinical and Experimental Immunology|September 1, 1990
Selective IgG subclass deficiency: quantification and clinical relevanceR Jefferis, D S Kumararatne
The Ceylon Medical Journal|March 1, 1976
Undiagnosed aortic stenosis--a cause of death after mitral valvotomyP T Chandrasoma, D S Kumararatne
Clinical and Experimental Immunology|June 26, 2001
From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathiesS Y Patel, D S Kumararatne
Immunology Today|October 8, 2014
Another look at chronic lymphocytic leukaemia in the context of B-cell differentiationD S Kumararatne, N R Ling
European Journal of Immunology|November 1, 1981
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursorsD S Kumararatne, I C MacLennan
Advances in Experimental Medicine and Biology|January 1, 1982
The origin of marginal-zone cellsD S Kumararatne, I C MacLennan
Lancet (London, England)|September 9, 1989
Hyper-IgE syndrome and H2-receptor blockadeR A Thompson, D S Kumararatne
Pageof 8